1. Introduction – Standard Operating Procedure (SOP) for Batch Packing of Nimesulide 100 mg Tablets:
The Standard Operating Procedure (SOP) for Batch Packing of Nimesulide 100 mg Tablets describes the systematic procedures, operational controls, documentation requirements, and quality assurance activities involved in the pharmaceutical packaging process. The objective of this SOP is to ensure that every batch of Nimesulide 100 mg Tablets is packed consistently, accurately, and in accordance with approved Batch Packing Records (BPR), Good Manufacturing Practices (GMP), and established quality standards. Nimesulide 100 mg Tablets, manufactured under the product name NOVOGESIC® Tablets in the supplied BPR, contain Nimesulide BP 100 mg per uncoated tablet. The packing procedure covers the receipt and verification of inspected tablets, dispensing of packaging materials, line clearance, overprinting verification, machine setup, blister or strip packing, secondary packaging, and finished product transfer. The SOP emphasizes the importance of line clearance, packaging material reconciliation, in-process quality checks, leak testing, batch coding verification, and rejection analysis to prevent product mix-ups, packaging defects, labeling errors, and potential contamination.Critical packaging parameters include sealing temperature, forming temperature, machine speed, packaging integrity, environmental conditions, and accuracy of printed information. In-process monitoring and documented verification by authorized Production and Quality Assurance personnel help ensure effective control throughout the packing operation. The procedure also establishes requirements for handling rejected packaging materials, documenting destruction activities, calculating packing yields, and completing final batch reconciliation. Proper implementation of this SOP supports product traceability, packaging integrity, patient safety, regulatory compliance, and effective batch review before finished product release. The ultimate purpose of this SOP is to ensure that Nimesulide 100 mg Tablets are packed safely, correctly identified, adequately protected, and consistently documented throughout the packaging process.
Skip to PDF content2. Batch Packing Record of Nimesulide 100 mg Tablets – Flow Diagram:
The flow diagram illustrates the systematic procedure for Batch Packing of Nimesulide 100 mg Tablets (NOVOGESIC®) in accordance with the approved Batch Packing Record (BPR) and Good Manufacturing Practices (GMP).
The process begins with the receipt of inspected tablets from the manufacturing department, followed by verification of product identity, batch details, and quantity. Approved packaging materials, including printed aluminium foil, PVC film, cartons, and shippers, are dispensed according to the packing schedule. Before initiating packing activities, Production and Quality Assurance personnel perform line clearance to ensure the area and equipment are clean and free from previous product materials. Subsequently, the blister or strip packing machine is set up, and operating parameters are checked. During primary packaging, in-process quality checks include sealing temperature verification, leak testing, packaging appearance, and overprinting accuracy. Secondary packaging involves carton filling, shipper packing, and verification of printed information.
3. Batch Packing Record of Nimesulide 100 mg Tablets – Critical Process Parameters (CPP) and Critical Quality Attributes (CQA):
The Standard Operating Procedure (SOP) for Batch Packing of Nimesulide 100 mg Tablets emphasizes the control of Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) to ensure consistent packaging quality, product identification, integrity, and compliance with Good Manufacturing Practices (GMP).
Critical Process Parameters (CPP):
Critical Process Parameters are operating conditions that require appropriate monitoring and control during packaging. Important parameters include sealing temperature, forming temperature, machine speed, sealing pressure, packaging material specifications, environmental conditions, and in-process inspection. These parameters influence blister formation, sealing performance, packaging consistency, and protection against moisture and physical damage. The Batch Packing Record requires verification of machine settings, environmental conditions, and periodic leak testing. Operating limits must be established through approved specifications, equipment qualification, and process validation, as applicable.
Critical Quality Attributes (CQA):
Critical Quality Attributes are measurable characteristics that must meet established acceptance criteria to ensure the quality of the packed product. Important packaging quality attributes include seal integrity, correct tablet count, accurate batch coding, manufacturing and expiry dates, packaging appearance, carton labeling, packing quantity, and finished pack integrity. Production and Quality Assurance personnel verify these attributes through documented in-process checks, leak testing, overprinting inspection, rejection analysis, and packaging material reconciliation.
Conclusion:
Effective control of CPPs and verification of CQAs help prevent packaging defects, product mix-ups, incorrect labeling, and compromised packaging integrity. These activities support product traceability, patient safety, and GMP compliance throughout the packing process.